Jupeng Yuan

4PUBLICATIONS
15CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Jun 03, 2026
Targeting XIAP-coordinated PKC signaling resensitizes PD-1-refractory tumors for rechallenge.

|Jun 30, 2022
Aberrant ROS Served as an Acquired Vulnerability of Cisplatin-Resistant Lung Cancer.

Qian Xin, Qinghong Ji, Ying Zhang

Pageof 1